Single-dose nimodipine normalizes impaired retinal circulation in normal tension glaucoma

Area of Science:

• Ophthalmology
• Cardiovascular Research
• Pharmacology

Background:

• Normal tension glaucoma (NTG) may benefit from calcium channel blockers, but mechanisms are unclear.
• Hemodynamic and neuroprotective effects are potential mechanisms for calcium channel blockers in NTG.
• This study investigates the hemodynamic effects of nimodipine on retinal circulation in NTG patients.

Purpose of the Study:

• To measure the hemodynamic effects of nimodipine on retinal circulation in normal tension glaucoma (NTG) patients.
• To investigate the potential of nimodipine to improve retinal blood flow in NTG.
• To compare retinal circulation in NTG patients with and without vasospastic symptoms before and after nimodipine administration.

Main Methods:

• Sixteen NTG patients with vasospastic symptoms and ten healthy controls were enrolled.
• Retinal capillary blood flow was measured using Scanning Laser Doppler Flowmetry.
• Measurements were taken before and 90 minutes after a single 30 mg oral dose of nimodipine.

Main Results:

• NTG patients had significantly reduced retinal capillary blood flow compared to controls (262 vs. 487 AU).
• Nimodipine increased retinal capillary blood flow in NTG patients by 91% (P < 0.001).
• Post-nimodipine blood flow in NTG patients reached levels comparable to healthy controls (440 vs. 439 AU).

Conclusions:

• NTG patients with vasospastic symptoms exhibit reduced retinal capillary blood flow.
• A single dose of nimodipine normalizes retinal circulation in these NTG patients.
• The findings suggest nimodipine's potential in managing NTG by improving hemodynamic parameters.